Front. Cell Dev. Biol.
Frontiers in Cell and Developmental Biology
Front. Cell Dev. Biol.
2296-634X
Frontiers Media S.A.
1074502
10.3389/fcell.2022.1074502
Cell and Developmental Biology
Erratum
Erratum: The role and therapeutic value of syndecan-1 in cancer metastasis and drug resistance
Frontiers Production Office
10.3389/fcell.2022.1074502
Frontiers Production Office
*
Frontiers Media SA, Lausanne, Switzerland
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
Approved by: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Cell and Developmental Biology
03
11
2022
2022
10
1074502
19
10
2022
19
10
2022
Copyright © 2022 Frontiers Production Office.
2022
Frontiers Production Office
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
An Erratum on The role and therapeutic value of syndecan-1 in cancer metastasis and drug resistance by Guo S, Wu X, Lei T, Zhong R, Wang Y, Zhang L, Zhao Q, Huang Y, Shi Y and Wu L (2022). Front. Cell Dev. Biol. 9:784983. doi: 10.3389/fcell.2021.784983
syndecan-1
metastasis
drug resistance
therapy
cancer
Due to a publishing error, the symbol which displays first co-authorship for authors Sen Guo, XinYi Wu, and Ting Lei was missing.
The publisher apologizes for the mistake. The original article has been updated.